Lipids online

Fri, 9 Jan 2004 23:03:30 GMT in article <[email hidden]>

Sonos said:

If you are looking for something to read....

lipidsonline.orglipidsonline.orgOpen ↗

A great web site! Thanks for the link!

--
Matti Narkia

Matti Narkia <[email hidden]> wrote in message news:<[email hidden]>...

Quoted message said:

Fri, 9 Jan 2004 23:03:30 GMT in article <[email hidden]> "Sonos"

Quoted message said:

If you are looking for something to read....

lipidsonline.orglipidsonline.orgOpen ↗

A great web site! Thanks for the link!

With all due respect Matti and Dr. Blanchard (I'm in a respectful mood this evening)I think those
looking for information on cholesterol and related issues, including medications, should take the
following into consideration. Note: two members of the editorial board, not included here, say they
have no significant interests or pharma relationships to declare (by their own definition.) All
information from the website mentioned above.

Web site "Supported by unrestricted educational grants from Merck US Human Health and Merck/Schering-
Plough."

Editorial Board financial disclosures:

Editorial Director, Dr. Ballantyne is engaged in research activities for AstraZeneca, diaDexus,
GlaxoSmithKline, Merck, Novartis, Pfizer, Reliant, and Schering-Plough. He is a consultant for
AstraZeneca, Merck, Novartis, Pfizer, Reliant, and Schering-Plough; and is a member of the speakers
bureaus for AstraZeneca, Bristol-Myers Squibb, Kos, Merck, Novartis, Pfizer, Reliant, and Schering-
Plough. He has received honoraria from AstraZeneca, Bristol Myers-Squibb, Kos, Merck, Novartis,
Pfizer, Reliant, and Schering-Plough.

Dr. Barter is engaged in research activities for Pfizer, Fournier and Glaxo-Welcome. He is a member
of the speakers bureaus for Merck & Co., AstraZeneca, and Pfizer.

Ds. Bersot is engaged in research activities with Bristol-Myers Squibb and Merck & Co. He is also a
consultant for Merck & Co. and is a member of the speakers bureaus for Bristol-Myers Squibb,
Merck & Co., and Parke Davis.

Dt. Brinton is engaged in research activities for Parke-Davis and Merck & Co. He is a consultant for
Novartis and is a member of the speakers bureaus for Parke-Davis, Merck, Bristol-Myers Squibb,
Abbott, Kos, Bayer, and Pfizer.

Du. Crouse is engaged in research activities and is a member of the speakers bureaus for Merck & Co.
and Bristol-Myers Squibb. He is also engaged in research activities for Kos. He is a member of
the speakers bureaus for Pfizer, Parke-Davis, Otsuka and Bayer.

Dv. Gotto is a consultant with Merck, Bristol-Myers Squibb, Parke-Davis, Pfizer, Novartis, Bayer,
and SmithKline Beecham.

Dw. Haffner is engaged in research activities and is a consultant for Merck & Co. He is a member of
the speakers bureaus for Parke-Davis and Merck & Co.

Dx. Jones is engaged in research activities for AstraZeneca and Pfizer.

Dy. Libby is a consultant with AstraZeneca, Avant Immunotherapeutics, Bayer, Bristol-Myers Squibb,
British Biotech, Groupe Fournier, Interleukin Genetics, Merck, Millennium Pharmaceuticals,
Novartis, Pfizer, Pierre Fabre, Sankyo, Sanofi, Schering-Plough, and SmithKline Beecham.

Dz. Miller is engaged in research activities, is a consultant for, and a member of the speakers
bureaus for Merck, Parke-Davis, Kos, and Bristol-Myers Squibb. He is also a consultant for and a
member of the speakers bureau for Pfizer. He is engaged in research activities for Novartis.

Dz. Rader is a consultant for and a member of the speakers bureau for Merck & Co.

Dz. Ridker is engaged in research activities for Bristol-Myers Squibb, Merck & Co., and
Dade Behring.

Dz. Bays has served as a clinical investigator for (and has received research grants from)
pharmaceutical companies such as AstraZeneca, Aura, Aventis, Bayer, Boehringer Mannheim, Bristol-
Myers Squibb, Fujisawa, Ciba Geigy, GelTex, Glaxo, Genetech, Hoechst Roussel, KOS, Lederle,
Marion Merrell Dow, Merck, Merck/Schering-Plough, Miles, Novartis, Parke-Davis, Pfizer, Roche,
Rorer, Regeneron, Sandoz, Sankyo, Sanofi, Schering-Plough, Searle, SmithKline Beecham, Takeda,
TAP, Upjohn, Upsher Smith, Warner Lambert, and Wyeth-Ayerst. Dr. Bays owns equities in KOS. He
has also served as a consultant, speaker, and/or advisor to and for companies such as
AstraZeneca, Aventis, Bayer, Bristol-Myers Squibb, KOS, Merck, Merck/Schering-Plough, Novartis,
Parke-Davis, Pfizer, Roche, Sandoz, Sankyo, Sanofi, Schering-Plough, SmithKline Beecham, Upjohn,
and Warner Lambert.

Dz. Bittner has conducted research for Wyeth Pharmaceuticals.

Dz. Collins is engaged in research activities for Merck, Bristol-Myers Squibb, Sanofi, and
AstraZeneca.

Dz. Fonarow is engaged in research activities, is a consultant for and a member of the speakers
bureaus for Merck and Bristol-Myers Squibb. He is a consultant for Scios. He is also a member of
the speakers bureaus for Pfizer, Glaxo SmithKline, and Scios.

Dz. Ginsberg is engaged in research for Bristol-Myers Squibb, SmithKline Beecham, Parke-Davis,
Pfizer, USPG, TAP, Schering Plough. He is a consultant for SmithKline Beecham, Parke-Davis,
Pfizer, USPG, and TAP. He is a member of the speakers bureau for Merck.

Dz. McKenney is engaged in research activities for Merck.

Dz. Nesto is a member of the speakers bureau for Merck.

Dz. Toth is a consultant for Merck. He is a member of the speakers bureaus for Merck, AstraZeneca,
Abbott, and Kos.

MFG

(mfg) said:

Web site "Supported by unrestricted educational grants from Merck US Human Health and Merck/Schering-
Plough."

Thanks for pointing this out.

--
Winning against heart attack and stroke sonoscore.comsonoscore.comOpen ↗

9 Jan 2004 18:11:31 -0800 in article

(mfg) said:

Matti Narkia <[email hidden]> wrote in message
news:<[email hidden]>...

Quoted message said:

Fri, 9 Jan 2004 23:03:30 GMT in article <[email hidden]> "Sonos"

Quoted message said:

If you are looking for something to read....

lipidsonline.orglipidsonline.orgOpen ↗

A great web site! Thanks for the link!

With all due respect Matti and Dr. Blanchard (I'm in a respectful mood this evening)I think those
looking for information on cholesterol and related issues, including medications, should take the
following into consideration. Note: two members of the editorial board, not included here, say they
have no significant interests or pharma relationships to declare (by their own definition.) All
information from the website mentioned above.

Thanks for you vigilance :-). Have to keep these connections in mind when browsing the web site.
Slides are useful though, IMHO.

--
Matti Narkia

"Sonos" <[email hidden]> wrote in message news:<[email hidden]>...

Quoted message said:

(mfg) said:

Web site "Supported by unrestricted educational grants from Merck US Human Health and Merck/Schering-
Plough."

Thanks for pointing this out.

You're very welcome Dr. Blanchard. It's beyond me why they think anyone would believe such a
disingenuous statement. One can only hope that lobbying by ethical members of your profession and a
concerned public will soon free medical research and education from such questionable
entanglements. MFG